SAN DIEGO – Revenue at ResMed Inc. increased 9% to $770.3 million; up 10% on a constant currency basis. The quarter ended June 30, 2020, also saw net operating profit increase of 84%, with non-GAAP operating profit up 24%. Revenue increased 13% to $3.0 billion; up 15% on a constant currency basis.

“Our fourth quarter results reflect the strength and resiliency of our business in today’s uncertain environment,” said Mick Farrell, ResMed’s CEO. “We finished fiscal year 2020 with double-digit revenue growth to $3.0 billion and operating profit up 24% on a non-GAAP basis,” “Throughout our fiscal fourth quarter, we continued to support the COVID-19 pandemic response through increased manufacturing of our ventilators, including bilevels, and ventilation mask systems while also supporting customers with digital health solutions and other innovative tools to enable remote care.

“Looking ahead, we are confident in our ability to navigate through the ongoing challenging clinical and economic environment to deliver for all our stakeholders,” Farrell continues. “Sleep labs and physician practices are reopening across many geographies, and we’re seeing accelerated adoption of digital health solutions which supports our long-term strategy. We remain vigilant and thoughtful about the outlook for our business as we continue to serve our customers, and we believe our strong foundation will accelerate our growth over the longer term.”